Table 5.
Programs providing data (N) | Sources of program funding | ||||||
---|---|---|---|---|---|---|---|
Government grants | Nongovernment grants | Professional organizations | University or school | Pharmaceutica 1 industry | Tobacco Industry | ||
All countries | 66 | 38 (58%) | 15 (23%) | 8 (12%) | 9 (14%) | 11 (17%) | 1 (2%) |
WHO Region | |||||||
African | 2 | 2 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Americas | 18 | 13 (72%) | 3 (17%) | 3 (17%) | 2 (11%) | 2 (11%) | 0 (0%) |
Eastern Mediterranean | 3 | 2 (67%) | 2 (67%) | 0 (0%) | 1 (33%) | 0 (0%) | 1 (25%) |
European | 25 | 11 (44%) | 3 (12%) | 3 (12%) | 6 (24%) | 7 (28%) | 0 (0%) |
South-East Asia | 7 | 3 (43%) | 2 (29%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Western Pacific | 11 | 7 (64%) | 5 (45%) | 2 (18%) | 0 (0%) | 2 (18%) | 0 (0%) |
Income Level | |||||||
High | 35 | 23 (66%) | 5 (14%) | 3 (9%) | 4 (11%) | 3 (9%) | 0 (0%) |
Middle | 28 | 12 (43%) | 10 (36%) | 5 (18%) | 5 (18%) | 8 (29%) | 1 (4%) |
Low | 3 | 3 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |